metformin and pasireotide

metformin has been researched along with pasireotide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertherat, J; Bisot-Locard, S; Borson-Chazot, F; Brue, T; Chanson, P; Cortet-Rudelli, C; Delemer, B; Reznik, Y; Tabarin, A; Vergès, B	1
Casanueva, FF; Colao, A; De Block, C; Gaztambide, MS; Kumar, S; Seufert, J	1
Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K	1

Reviews

2 review(s) available for metformin and pasireotide

Article	Year
Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide. Diabetes & metabolism, 2013, Volume: 39, Issue:1 Topics: Biomarkers; Blood Glucose; Clinical Trials as Topic; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hydrocortisone; Hyperglycemia; Hypoglycemic Agents; Metformin; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Hormones; Practice Guidelines as Topic; Recurrence; Somatostatin	2013
Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations. Pituitary, 2014, Volume: 17, Issue:2 Topics: Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Metformin; Pituitary ACTH Hypersecretion; Receptors, Glucagon; Somatostatin; Treatment Outcome	2014

Article

Year

Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide.

Diabetes & metabolism, 2013, Volume: 39, Issue:1

Topics: Biomarkers; Blood Glucose; Clinical Trials as Topic; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hydrocortisone; Hyperglycemia; Hypoglycemic Agents; Metformin; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Hormones; Practice Guidelines as Topic; Recurrence; Somatostatin

2013

Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations.

Pituitary, 2014, Volume: 17, Issue:2

Topics: Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Metformin; Pituitary ACTH Hypersecretion; Receptors, Glucagon; Somatostatin; Treatment Outcome

2014

Trials

1 trial(s) available for metformin and pasireotide

Article	Year
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study. Diabetes research and clinical practice, 2014, Volume: 103, Issue:3 Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult	2014

Article

Year

Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.

Diabetes research and clinical practice, 2014, Volume: 103, Issue:3

Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult

2014